GPA Annual Report
(April 2018 - March 2019)


In cooperation within the ILDS Project Grand Challenges of Global Skin Health IFPA, ILDS and IPC have agreed to cooperate within this area of mutual interest to increase the understanding of the global burden of psoriasis, through the development of a Global Psoriasis Atlas based on existing data and future studies.

How can you support the GPA?

Establishing a sustainable high quality GPA requires the support of industry, organisations with relevant datasets and collaboration across regions and countries.
If you or your organisation is interested in contributing to the development of the GPA via monetary or in-kind contributions, or wish to undertake research relevant to the GPA, please contact the GPA Programme Manager, Rebekah Swan.


The Global Psoriasis Atlas is supported by grants from LEO Foundation and Novartis Pharma AG and is sponsored by AbbVie and Eli Lilly UK and Company Limited.


Lead supporter

Other supporters